Lamisil At (terbinafine Antifungal recalls

The FDA has published 1 recall involving Lamisil At (terbinafine Antifungal since 2013. The latest was reported on 12 Jun 2013. Most were for packaging defects. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2013

Last 12 months0reported

Class I00% of total

Ongoing0latest 12 Jun 2013

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 1 100%

Why lamisil at (terbinafine antifungal is recalled

Packaging Defects1100%

Companies

Novartis Consumer Health1100%

By year

20131100%

All lamisil at (terbinafine antifungal recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
12 Jun 2013Drug	CLASS III	Lamisil AT Cream (terbinafine hydrochloride 1% antifungal) recalled	Novartis Consumer Health	Packaging Defects	Nationwide

Should you stop taking Lamisil At (terbinafine Antifungal?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.